Home Applications 020822 Application 020822
Type NDA
Sponsor ALLERGAN Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 CELEXA CITALOPRAM HYDROBROMIDE TABLET;ORAL EQ 10MG BASE Yes No 002 CELEXA CITALOPRAM HYDROBROMIDE TABLET;ORAL EQ 20MG BASE Yes No 003 CELEXA CITALOPRAM HYDROBROMIDE TABLET;ORAL EQ 40MG BASE Yes Yes 004 CELEXA CITALOPRAM HYDROBROMIDE TABLET;ORAL EQ 60MG BASE No No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 4 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N020822-001 CELEXA CITALOPRAM HYDROBROMIDE EQ 10MG BASE TABLET / ORAL AB RLD 2000-04-27 N020822-002 CELEXA CITALOPRAM HYDROBROMIDE EQ 20MG BASE TABLET / ORAL AB RLD 1998-07-17 N020822-003 CELEXA CITALOPRAM HYDROBROMIDE EQ 40MG BASE TABLET / ORAL AB RLD, RS 1998-07-17 N020822-004 CELEXA CITALOPRAM HYDROBROMIDE EQ 60MG BASE TABLET / ORAL 1998-07-17
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 3 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 5 · 164 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N020822-001 CELEXA EQ 10MG BASE TABLET / ORAL AB RLD 2000-04-27 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N020822-002 CELEXA EQ 20MG BASE TABLET / ORAL AB RLD 1998-07-17 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N020822-003 CELEXA EQ 40MG BASE TABLET / ORAL AB RLD, RS 1998-07-17 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N020822-004 CELEXA EQ 60MG BASE TABLET / ORAL 1998-07-17 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N020822-001 CELEXA EQ 10MG BASE TABLET / ORAL AB RLD 2000-04-27 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N020822-002 CELEXA EQ 20MG BASE TABLET / ORAL AB RLD 1998-07-17 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N020822-003 CELEXA EQ 40MG BASE TABLET / ORAL AB RLD, RS 1998-07-17 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N020822-004 CELEXA EQ 60MG BASE TABLET / ORAL 1998-07-17 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N020822-001 CELEXA EQ 10MG BASE TABLET / ORAL AB RLD 2000-04-27 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N020822-002 CELEXA EQ 20MG BASE TABLET / ORAL AB RLD 1998-07-17 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N020822-003 CELEXA EQ 40MG BASE TABLET / ORAL AB RLD, RS 1998-07-17 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N020822-004 CELEXA EQ 60MG BASE TABLET / ORAL 1998-07-17 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N020822-001 CELEXA EQ 10MG BASE TABLET / ORAL AB RLD 2000-04-27 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N020822-002 CELEXA EQ 20MG BASE TABLET / ORAL AB RLD 1998-07-17 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N020822-003 CELEXA EQ 40MG BASE TABLET / ORAL AB RLD, RS 1998-07-17 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N020822-004 CELEXA EQ 60MG BASE TABLET / ORAL 1998-07-17 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N020822-001 CELEXA EQ 10MG BASE TABLET / ORAL AB RLD 2000-04-27 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N020822-002 CELEXA EQ 20MG BASE TABLET / ORAL AB RLD 1998-07-17 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N020822-003 CELEXA EQ 40MG BASE TABLET / ORAL AB RLD, RS 1998-07-17 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N020822-004 CELEXA EQ 60MG BASE TABLET / ORAL 1998-07-17 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N020822-001 CELEXA EQ 10MG BASE TABLET / ORAL AB RLD 2000-04-27 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N020822-002 CELEXA EQ 20MG BASE TABLET / ORAL AB RLD 1998-07-17 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N020822-003 CELEXA EQ 40MG BASE TABLET / ORAL AB RLD, RS 1998-07-17 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N020822-004 CELEXA EQ 60MG BASE TABLET / ORAL 1998-07-17 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N020822-001 CELEXA EQ 10MG BASE TABLET / ORAL AB RLD 2000-04-27 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N020822-002 CELEXA EQ 20MG BASE TABLET / ORAL AB RLD 1998-07-17 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N020822-003 CELEXA EQ 40MG BASE TABLET / ORAL AB RLD, RS 1998-07-17 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N020822-004 CELEXA EQ 60MG BASE TABLET / ORAL 1998-07-17 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N020822-001 CELEXA EQ 10MG BASE TABLET / ORAL AB RLD 2000-04-27 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N020822-002 CELEXA EQ 20MG BASE TABLET / ORAL AB RLD 1998-07-17 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N020822-003 CELEXA EQ 40MG BASE TABLET / ORAL AB RLD, RS 1998-07-17 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N020822-004 CELEXA EQ 60MG BASE TABLET / ORAL 1998-07-17 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N020822-001 CELEXA EQ 10MG BASE TABLET / ORAL AB RLD 2000-04-27 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N020822-002 CELEXA EQ 20MG BASE TABLET / ORAL AB RLD 1998-07-17 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N020822-003 CELEXA EQ 40MG BASE TABLET / ORAL AB RLD, RS 1998-07-17 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N020822-004 CELEXA EQ 60MG BASE TABLET / ORAL 1998-07-17 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N020822-001 CELEXA EQ 10MG BASE TABLET / ORAL AB RLD 2000-04-27 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N020822-002 CELEXA EQ 20MG BASE TABLET / ORAL AB RLD 1998-07-17 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N020822-003 CELEXA EQ 40MG BASE TABLET / ORAL AB RLD, RS 1998-07-17 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N020822-004 CELEXA EQ 60MG BASE TABLET / ORAL 1998-07-17 d06236e962d9…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 4 · 123 observed states.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 15 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 0456-4010 Celexa citalopram Allergan, Inc. NDA Current 0456-4010 Celexa citalopram Allergan, Inc. NDA Current 0456-4010 Celexa citalopram Allergan, Inc. NDA Current 0456-4010 Celexa citalopram Allergan, Inc. NDA Current 0456-4010 Celexa citalopram Allergan, Inc. NDA Current 0456-4020 Celexa citalopram Allergan, Inc. NDA Current 0456-4020 Celexa citalopram Allergan, Inc. NDA Current 0456-4020 Celexa citalopram Allergan, Inc. NDA Current 0456-4020 Celexa citalopram Allergan, Inc. NDA Current 0456-4020 Celexa citalopram Allergan, Inc. NDA Current 0456-4040 Celexa citalopram Allergan, Inc. NDA Current 0456-4040 Celexa citalopram Allergan, Inc. NDA Current 0456-4040 Celexa citalopram Allergan, Inc. NDA Current 0456-4040 Celexa citalopram Allergan, Inc. NDA Current 0456-4040 Celexa citalopram Allergan, Inc. NDA Current